Fast Result
Only 15 minutes after Test, the result is ready
Long Shelf Life
24 months Shelf Life after date of manufacture
POINT-OF-CARE TEST for COVID-19
Easy to use, producing a fast result in 15 minutes and with a long shelf life of 24 months after the date of manufacture, SGTi-flex COVID-19 Ag includes the option of using either a comfortable Nasal Swab to collect a nasal sample or a Nasopharyngeal Swab to collect a nasopharyngeal sample for the Test
ARTG ID: 412813
- Very High Accuracy
- Very High Sensitivity
- Very High Specificity
- Test Kit size: 25 Tests Kit
- External Control Solutions can be purchased separately
Test for COVID-19
The Test is a quick and easy to use Rapid Antigen Test (RAT) that qualitatively detects the presence or absence of the SARS-CoV-2 virus (which is the virus that causes COVID-19 disease).
The Test uses a lateral flow immunoassay to qualitatively detect the presence or absence of the nucleocapsid protein antigen of the SARS-CoV-2 virus in the sample used in the Test.
Fast Result
in 15 Minutes
The Test produces a Fast Result in 15 minutes.
Long Shelf Life of 24 Months
after date of manufacture -
Helps reduce wastage
The Test has a Long Shelf Life of 24 months after the date of manufacture, which is backed up by a scientific study carried out over that time period.
A longer Shelf Life helps you to retain your supplies of the Test for longer and helps to reduce wastage from having to throw away tests that have reached the end of their Shelf Life, which can be more of an issue with tests that have a shorter Shelf Life.
Bulk orders – Request a quote
Bulk orders of the Test are available for delivery Australia-wide.
Request a Quote now or Contact us and one of our knowledgeable and friendly staff members will assist you.
As this product is a Point-of-Care Test (not a Self-Test), it is only available for sale to certain types of persons and organisations who are authorised by the Australian Government to purchase Point-of-Care Tests.
SGTi-flex COVID-19 Ag
A one step, lateral flow immunoassay test for the qualitative detection of the SARS-CoV-2 antigen in human nasal specimen or human nasopharyngeal specimen.
This product is not a Self-Test product and is not to be used as a Self-Test product.
This product is not available for sale to the general public.
This product is a Point-of-Care Test (also known as a “Professional Test”) which is intended to be used only by trained laboratory staff or healthcare professionals to carry out a test on another person.
This product is only available for sale to certain types of persons and organisations who are authorised by the Australian Government to purchase this type of product.
Accuracy – Nasal specimen
(Overall percent agreement)
Sensitivity (Positive percent agreement): 91.4%
Specificity (Negative percent agreement): 99.8%
Accuracy – Nasopharyngeal specimen
(Overall percent agreement)
Sensitivity (Positive percent agreement): 86.3%
Specificity (Negative percent agreement): 100.0%
Available in 25 Tests Kit size
25 Tests Kit
Test Kit components
The Test Kit includes all components needed to carry out a test.
There is no need for any additional components.
25 Tests Kit
How to use
The Test Kit includes comprehensive Instructions for Use that give a step-by-step explanation on how to use the Test.
Instructions for Use
Always follow the Instructions for Use before, during and after using the Test. The Instructions for Use are included as a paper leaflet in each Test Kit.
View and download the Instructions for Use here:
Regulatory approval in Australia
ARTG ID: 412813
The Test has obtained regulatory approval for use throughout Australia by the addition of the Test to the Australian Register of Therapeutic Goods (ARTG).
The Test has ARTG ID 412813.
TGA Q&As on COVID-19 Rapid Antigen Point-of-Care Tests
The relevant Australian Government regulatory agency, the Therapeutic Goods Administration (TGA), has published a list of Questions and Answers on COVID-19 Rapid Antigen Point-of-Care Tests.
View the TGA Q&As here:
We are waiting for you to contact us about
SGTi-flex COVID-19 Ag
High quality medical and healthcare products
Involution Healthcare are bringing next-generation pioneering technologies to Australia and New Zealand